Christopher J. Darus, MD
Christopher J. Darus, MD
Attending Physician
Maine Medical Partners
100 Campus Drive
Suite 125
Scarborough,
ME
USA
04074
Papers:
53
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study
A Phase II Evaluation of Cediranib in the Treatment of Recurrent or Persistent Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study